Qube Research & Technologies (QRT)
VRDN icon

Qube Research & Technologies (QRT)’s Viridian Therapeutics VRDN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.52M Buy
231,270
+101,738
+79% +$3.02M 0.01% 1715
2025
Q4 		$4.03M Buy
+129,532
New +$3.55M 0.01% 1890
2025
Q1 		– Sell
-28,809
Closed -$552K – 3994
2024
Q4 		$552K Buy
+28,809
New +$626K ﹤0.01% 2425
2022
Q2 		– Sell
-33,187
Closed -$614K – 3179
2022
Q1 		$614K Buy
33,187
+16,187
+95% +$311K 0.01% 1431
2021
Q4 		$336K Buy
+17,000
New +$317K ﹤0.01% 1753
2020
Q4 		– Sell
-24,447
Closed -$284K – 2244
2020
Q3 		$284K Buy
24,447
+20,447
+511% +$305K ﹤0.01% 1267
2020
Q2 		$67K Buy
+4,000
New +$45.4K ﹤0.01% 1566

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return